Hosted on MSN1mon
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022Among privately insured U.S. adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers and hormones was rare from 2018 to 2022, according to a research letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback